News

Landmark Legal Battle: Family Fights for Accountability in Addiction Treatment Coverage Denials

In a heartbreaking case that has drawn attention to the failures of addiction treatment coverage in the U.S., Maureen O’Reilly is suing Horizon Blue Cross and Blue Shield and Beacon Health Options. The lawsuit alleges that their repeated denials of medically necessary addiction treatment led to the tragic death of her 28-year-old son, Ed Fahy. Represented by John J. Zidziunas & Associates, O’Reilly’s case not only seeks justice for her son but also highlights systemic issues that plague addiction treatment and health insurance in the United States.

A Life Lost Amid Systemic Failures

Ed Fahy’s battle with addiction began in his late teens but became dire in 2016. Struggling with opioid, cocaine, and alcohol dependency, Ed agreed to seek inpatient treatment near his family in New Jersey. His mother, Maureen O’Reilly, believed her health insurance plan through Horizon would provide the care her son desperately needed. However, Horizon and its behavioral health partner, Beacon Health Options, denied requests for coverage at two New Jersey facilities, despite them being in-network and recommended by Ed’s medical providers.

With no approved local options, the family found themselves forced to send Ed to Florida, where treatment was covered. Florida’s addiction care system, often referred to as the “Florida Shuffle,” is notorious for its lack of regulation and abundance of low-quality treatment centers and sober homes. Ed became trapped in this broken system, facing multiple relapses and transfers between facilities that failed to provide adequate care.

In September 2016, Ed overdosed on fentanyl and cocaine in a poorly run sober living home in Palm Beach County, Florida. The facility was later shut down by law enforcement for patient brokering — a practice where treatment centers profit from referrals rather than focusing on patient outcomes.

A Mother’s Fight for Justice

Maureen O’Reilly’s lawsuit, filed in 2018, claims that Horizon and Beacon’s repeated denials of care violated their contractual obligations, fiduciary duty, and state laws, leading to Ed’s “wrongful death.” O’Reilly is determined to hold these insurers accountable for what she describes as systemic failures that stripped her son of a chance at recovery.

"You can’t be yanked out of this place and that place and sent to the worst place in the United States to recover," O’Reilly said. Her fight is not only for Ed but for the countless families who face similar challenges in securing proper addiction care.

Insurance Barriers to Addiction Treatment

Ed Fahy’s story underscores the widespread issues families face when seeking addiction treatment. Inconsistent insurance coverage is one of the biggest obstacles, with denials often based on opaque or arbitrary criteria. Studies show that in 2018 alone, approximately 100,000 Americans in need of addiction treatment were unable to receive it due to inadequate insurance coverage.

In Ed’s case, Horizon and Beacon repeatedly denied medically necessary inpatient treatment at facilities in New Jersey. Medical notes obtained by O’Reilly after Ed’s death revealed that a Beacon review conducted weeks later acknowledged these treatments should have been approved. By then, it was too late.

Experts argue that insurance companies frequently employ tactics designed to discourage appeals, such as denying coverage outright or recommending lower levels of care that are insufficient for the patient’s needs. “Insurers bank on families and consumers not having the capacity to appeal these decisions,” said Ellen Weber, vice president of health initiatives at the Legal Action Center.

The Crisis of Addiction Treatment in America

Ed Fahy’s story is emblematic of the larger crisis in addiction treatment in the United States. Despite federal and state laws like the Mental Health Parity and Addiction Equity Act (2008) and the Affordable Care Act (2010), which mandate equal coverage for mental health and physical health care, insurers frequently fall short.

The opioid epidemic, which has claimed more than 700,000 lives since 1999, has further exposed the gaps in the U.S. addiction treatment system. High costs, low quality, and inconsistent insurance coverage leave families struggling to find appropriate care.

In many cases, addiction treatment is still viewed as outside mainstream healthcare, and insurers are reluctant to pay for it. This leads to substandard facilities, limited access, and poor outcomes for patients. “If insurers deny addiction treatment based on quality concerns, they should also provide access to better options,” said Richard Frank, a health economist at Harvard University.

A Call for Systemic Reform

O’Reilly’s lawsuit comes at a time when advocates are pushing for meaningful reform in addiction treatment and insurance practices. Insurers have a critical role to play in improving care by not only covering evidence-based treatments but also setting higher quality standards for facilities.

Some progress is being made. Insurers like Horizon and Beacon have partnered with organizations like Shatterproof to develop standards for addiction care. However, enforcement of existing laws remains inconsistent. A study by consulting firm Milliman found that insurers often pay significantly less for behavioral health services than physical health care, and addiction services are up to 5.8 times more likely to be out of network, making them more expensive and harder to access.

A Mother’s Message to the Industry

As a public defender, Maureen O’Reilly has witnessed many clients struggling with addiction, often forced into state-mandated treatment programs. Reflecting on her own son’s journey, she says the system’s failures are both personal and systemic.

“I don’t think the health insurance industry understands the stakes,” O’Reilly said. “They need to be reined in. These decisions are life and death.”

For O’Reilly, the fight is about more than just her family. It’s about preventing similar tragedies for others. “At the end of the day, I want the insurance companies to understand that they can’t treat addiction care as optional. It’s not just numbers on a balance sheet. It’s lives.”

As the case moves forward, it represents a significant moment in the ongoing battle for accountability and reform in addiction treatment. O’Reilly’s determination, supported by John J. Zidziunas & Associates, serves as a powerful reminder of the need to prioritize care over cost and compassion over profit.

‍

BACK TO BLOG

News

Insights